| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial
|
de Boer, Stephanie M
|
|
|
20 |
9 |
p. 1273-1285
|
artikel
|
| 2 |
Advancing cancer care and prevention in the Caribbean: a survey of strategies for the region
|
Spence, Dingle
|
|
|
20 |
9 |
p. e522-e534
|
artikel
|
| 3 |
A European paediatric cancer mission: aspiration or reality?
|
Kearns, Pamela R
|
|
|
20 |
9 |
p. 1200-1202
|
artikel
|
| 4 |
AZD1775 plus chemoradiotherapy for pancreatic cancer
|
Burki, Talha Khan
|
|
|
20 |
9 |
p. e472
|
artikel
|
| 5 |
Barriers to treatment for patients with breast cancer in Kenya
|
Zolnikov, Tara Rava
|
|
|
20 |
9 |
p. 1206-1207
|
artikel
|
| 6 |
Bone metastases as initial presentation of hepatocellular carcinoma
|
Belli, Andrea
|
|
|
20 |
9 |
p. e549
|
artikel
|
| 7 |
Cancer control in small island nations: from local challenges to global action
|
Sarfati, Diana
|
|
|
20 |
9 |
p. e535-e548
|
artikel
|
| 8 |
Cancer control in small island nations: too often overlooked
|
Gourd, Katherine
|
|
|
20 |
9 |
p. 1199-1200
|
artikel
|
| 9 |
Cancer control in the Caribbean island countries and territories: some progress but the journey continues
|
Spence, Dingle
|
|
|
20 |
9 |
p. e503-e521
|
artikel
|
| 10 |
Cancer control in the Pacific: big challenges facing small island states
|
Sarfati, Diana
|
|
|
20 |
9 |
p. e475-e492
|
artikel
|
| 11 |
Cancer management in the Pacific region: a report on innovation and good practice
|
Ekeroma, Alec
|
|
|
20 |
9 |
p. e493-e502
|
artikel
|
| 12 |
Chemoimmunotherapy for stage IV non-small-cell lung cancer
|
Uprety, Dipesh
|
|
|
20 |
9 |
p. e466
|
artikel
|
| 13 |
Chemoimmunotherapy for stage IV non-small-cell lung cancer – Authors' reply
|
Cappuzzo, Federico
|
|
|
20 |
9 |
p. e467
|
artikel
|
| 14 |
Collection of routine cancer data from private health-care providers
|
Spencer, Katie
|
|
|
20 |
9 |
p. 1202-1204
|
artikel
|
| 15 |
Combining PARP inhibition with PD-1 inhibitors
|
Lassen, Ulrik
|
|
|
20 |
9 |
p. 1196-1198
|
artikel
|
| 16 |
Correction to Lancet Oncol 2019; 20: 1273–85
|
|
|
|
20 |
9 |
p. e468
|
artikel
|
| 17 |
Correction to Lancet Oncol 2019; 20: 1171–82
|
|
|
|
20 |
9 |
p. e468
|
artikel
|
| 18 |
Correction to Lancet Oncol 2019; 20: 1148–59
|
|
|
|
20 |
9 |
p. e468
|
artikel
|
| 19 |
Correction to Lancet Oncol 2019; 20: 1211–25
|
|
|
|
20 |
9 |
p. e468
|
artikel
|
| 20 |
Correction to Lancet Oncol 2019; 20: e417–33
|
|
|
|
20 |
9 |
p. e468
|
artikel
|
| 21 |
Correction to Lancet Oncol 2019; 20: e503–21
|
|
|
|
20 |
9 |
p. e468
|
artikel
|
| 22 |
Disability in cancer care: time for change?
|
The Lancet Oncology,
|
|
|
20 |
9 |
p. 1183
|
artikel
|
| 23 |
Erdafitinib for advanced urothelial carcinoma
|
Burki, Talha Khan
|
|
|
20 |
9 |
p. e469
|
artikel
|
| 24 |
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
|
Calais, Jeremie
|
|
|
20 |
9 |
p. 1286-1294
|
artikel
|
| 25 |
Fusion gene-oriented precision medicine in soft tissue sarcoma
|
Araki, Nobuhito
|
|
|
20 |
9 |
p. 1189-1190
|
artikel
|
| 26 |
Global burden of childhood cancer: growing, but controllable
|
Stiller, Charles A
|
|
|
20 |
9 |
p. 1184-1185
|
artikel
|
| 27 |
Ibrutinib and rituximab for chronic lymphocytic leukaemia
|
Stirrups, Robert
|
|
|
20 |
9 |
p. e471
|
artikel
|
| 28 |
Is reducing irradiated margins key to improving outcomes for radiotherapy?
|
van Herk, Marcel
|
|
|
20 |
9 |
p. 1208-1210
|
artikel
|
| 29 |
Management of high-risk endometrial cancer: are we there yet?
|
Randall, Marcus
|
|
|
20 |
9 |
p. 1192-1193
|
artikel
|
| 30 |
MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc)
|
Narod, Steven A
|
|
|
20 |
9 |
p. e465
|
artikel
|
| 31 |
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
|
Saura, Cristina
|
|
|
20 |
9 |
p. 1226-1238
|
artikel
|
| 32 |
Non-radioactive imaging for SLN detection in melanoma
|
Das, Manjulika
|
|
|
20 |
9 |
p. e473
|
artikel
|
| 33 |
Overcoming endocrine resistance in neoadjuvant endocrine therapy for early breast cancer
|
Jackisch, Christian
|
|
|
20 |
9 |
p. 1185-1187
|
artikel
|
| 34 |
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial
|
Adkins, Douglas
|
|
|
20 |
9 |
p. 1295-1305
|
artikel
|
| 35 |
Palbociclib: a new partner for cetuximab?
|
Strohbehn, Garth W
|
|
|
20 |
9 |
p. 1195-1196
|
artikel
|
| 36 |
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial
|
Friedlander, Michael
|
|
|
20 |
9 |
p. 1306-1315
|
artikel
|
| 37 |
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
|
Stacchiotti, Silvia
|
|
|
20 |
9 |
p. 1252-1262
|
artikel
|
| 38 |
Pazopanib or methotrexate–vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study
|
Toulmonde, Maud
|
|
|
20 |
9 |
p. 1263-1272
|
artikel
|
| 39 |
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
|
Robert, Caroline
|
|
|
20 |
9 |
p. 1239-1251
|
artikel
|
| 40 |
Radical surgery for cervical cancer
|
Raspagliesi, Francesco
|
|
|
20 |
9 |
p. 1198-1199
|
artikel
|
| 41 |
Surgical resection based on ontogenetic cancer field theory for cervical cancer: mature results from a single-centre, prospective, observational, cohort study
|
Höckel, Michael
|
|
|
20 |
9 |
p. 1316-1326
|
artikel
|
| 42 |
TCR gene therapy for HPV-associated epithelial cancers
|
Burki, Talha Khan
|
|
|
20 |
9 |
p. e474
|
artikel
|
| 43 |
The emerging role of PET-CT scan after radical prostatectomy: still a long way to go
|
Fossati, Nicola
|
|
|
20 |
9 |
p. 1193-1195
|
artikel
|
| 44 |
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
|
|
|
|
20 |
9 |
p. 1211-1225
|
artikel
|
| 45 |
The necessity for rigour in rare disease study design
|
Baker, Laurence H
|
|
|
20 |
9 |
p. 1190-1192
|
artikel
|
| 46 |
US Government targets foreign researchers
|
Furlow, Bryant
|
|
|
20 |
9 |
p. 1205
|
artikel
|
| 47 |
5-year results for pembrolizumab treatment of advanced melanoma
|
Hassel, Jessica C
|
|
|
20 |
9 |
p. 1187-1189
|
artikel
|
| 48 |
Zanubrutinib in B-cell malignancies
|
Das, Manjulika
|
|
|
20 |
9 |
p. e470
|
artikel
|
Tijdschrift beschrijving